| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |